阿迪波涅丁信号改善了2型糖尿病小鼠的认知功能障碍,通过激活海马体的AdipoR2-PPARα/CREB通路
Hongyan Gong1,2, Yanli Liu2, Liu Xia2,3
1MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
Molecular neurobiology
|November 19, 2025
概括
一种新药AdipRon可以通过向海马体的皮连结素系统来逆转2型糖尿病的认知衰退. 这为治疗糖尿病相关认知障碍提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病相关认知障碍 (DACI) 是2型糖尿病 (T2DM) 的严重并发症.
- hippocampal adiponectin (APN) 系统在 DACI 病变发生中的作用尚未完全理解.
- 皮菌素受体2 (AdipoR2) 对神经元功能至关重要,可能与DACI有关.
研究的目的:
- 研究海马APN系统在DACI中的作用.
- 评估AdipoRon的治疗潜力,一个口服APN受体激动剂,用于DACI.
- 阐明AdipoRon作用的潜在分子机制.
主要方法:
- 通过高脂肪饮食和链杆菌素建立了T2DM的小鼠模型.
- 用行为测试评估认知功能.
- 分析了海马体AdipoR2表达,突触后蛋白水平,神经炎症标记物和信号通路 (PPARα/CREB).
- 使用HT22海马神经元进行了体外研究.
主要成果:
- T2DM小鼠表现出认知缺陷和降低海马体AdipoR2表达.
- 在T2DM小鼠中,AdipoRon治疗改善了认知功能和代谢参数.
- 阿迪波调高了阿迪波R2,恢复了突触后蛋白质,减弱了神经炎症,并激活了PPARα/CREB通路.
- 在体外,AdipoRon通过一种依赖PPARα的机制表现出神经保护作用.
结论:
- 海马体AdipoR2下调是DACI的一个关键因素.
- 在T2DM小鼠模型中,AdipoRon有效地逆转认知障碍.
- 阿迪波通过阿迪波R2/PPARα/CREB通路起作用,代表了DACI的一种有前途的治疗策略.
更多相关视频
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
10.8K
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
2.0K
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Type I Diabetes II: Pathophysiology
122
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
122
Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Type II Diabetes II: Pathophysiology
45
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
45
